BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Niro GA, Ferro A, Cicerchia F, Brascugli I, Durazzo M. Hepatitis delta virus: From infection to new therapeutic strategies. World J Gastroenterol 2021; 27(24): 3530-3542 [PMID: 34239267 DOI: 10.3748/wjg.v27.i24.3530]
URL: https://www.wjgnet.com/1007-9327/full/v27/i24/3530.htm
Number Citing Articles
1
Felice Alfonso Nava, Giulia Bassetti, Marco Cristofoletti, Massimo Fornaini, Raffaele Geraci, Marina Paties, Carlo Poggi, Stefano Tolio, Claudio Pilerci. Hepatitis delta is a public health concern in the community setting: The role of prison health care units in limiting the spread of infection in general populationMISSION 2022; (56): 43 doi: 10.3280/mis56-2020oa12975
2
Jackson Alves da Silva Queiroz, Tárcio Peixoto Roca, Rutilene Barbosa Souza, Luiz Fellype Alves de Souza, Ana Maísa Passos-Silva, André Luiz Ferreira da Silva, Eugênia de Castro e Silva, Lourdes Maria Pinheiro Borzacov, Rita de Cássia Pontello Rampazzo, Soraya dos Santos Pereira, Thor Oliveira Dantas, Janaína Mazaro, Lívia Melo Villar, Juan Miguel Villalobos Salcedo, Daniel Archimedes da Matta, Deusilene Vieira. Development of quantitative multiplex RT-qPCR one step assay for detection of hepatitis delta virusScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-37756-z
3
Laura Iulia Grecu, Mariana Pavel-Tanasa, Lilia Matei, Camelia Sultana, Simona Maria Ruta, Razvan Ioan Grecu, Ramona Gabriela Ursu, Petru Cianga, Luminita Smaranda Iancu. Molecular Epidemiology of Hepatitis D Virus in the North-East Region of RomaniaPathogens 2024; 13(9): 793 doi: 10.3390/pathogens13090793
4
Felice Alfonso Nava, Loreta A. Kondili. The HBV/HDV screening and linkage to care in drug users: A therapeutic diagnostic pathway (PDTA)MISSION 2024; (63): 18 doi: 10.3280/mis63-64-2023oa17586
5
Jeffrey V. Lazarus, Ahmad Al‐Rifai, Faisal M. Sanai, Abdullah Saeed Alghamdi, Ala I. Sharara, Motaz Fathy Saad, Lena van Selm, Saleh A. Alqahtani. Hepatitis delta virus infection prevalence, diagnosis and treatment in the Middle East: A scoping reviewLiver International 2023; 43(S1): 116 doi: 10.1111/liv.15338
6
Roxana Nemteanu, Andreea Clim, Corina Elena Hincu, Liliana Gheorghe, Irina Ciortescu, Alina Plesa. Interferon-Free Regimens and Direct-Acting Antiviral Agents for Delta Hepatitis: Are We There Yet?Current Issues in Molecular Biology 2023; 45(10): 7878 doi: 10.3390/cimb45100498
7
Margaux J. Heuschkel, Charlotte Bach, Laura Meiss-Heydmann, Emma Gerges, Emanuele Felli, Fabio Giannone, Patrick Pessaux, Catherine Schuster, Julie Lucifora, Thomas F. Baumert, Eloi R. Verrier. JAK1 promotes HDV replication and is a potential target for antiviral therapyJournal of Hepatology 2024; 80(2): 220 doi: 10.1016/j.jhep.2023.10.030
8
Ankita Kaushik, Geoffrey Dusheiko, Chong Kim, Nathaniel J. Smith, Csilla Kinyik-Merena, Gian Luca Di Tanna, Robert J. Wong. Understanding the Natural History of Chronic Hepatitis D: Proposal of a Model for Cost-Effectiveness StudiesPharmacoEconomics - Open 2024; 8(2): 333 doi: 10.1007/s41669-023-00466-3
9
Daniel G. Sausen, Oren Shechter, William Bietsch, Zhenzhen Shi, Samantha M. Miller, Elisa S. Gallo, Harel Dahari, Ronen Borenstein. Hepatitis B and Hepatitis D Viruses: A Comprehensive Update with an Immunological FocusInternational Journal of Molecular Sciences 2022; 23(24): 15973 doi: 10.3390/ijms232415973
10
Bibigul S. Ilyassova, Balzhan Abzhaparova, Dariga S. Smailova, Aidos Bolatov, Bolatbek Baymakhanov, Vyacheslav Beloussov, Maxim Solomadin, Kunsulu Shamsivaliyeva, Gulnara Alpysbayava, Gaukhar Issakova, Joanna Granica, Dina Mukushkina, Inkar Y. Sagatov, Shokan Kaniyev. Prevalence and genotypes distribution of virus hepatitis B and hepatitis delta virus in chronic liver diseases in KazakhstanBMC Infectious Diseases 2023; 23(1) doi: 10.1186/s12879-023-08524-1
11
Licel de los Ángeles Rodríguez Lay, Zexi Tan, Maria Caridad Montalvo Villalba, Marcia Samada Suárez, Marité Bello Corredor, Dayesi López Hernández, Barbara Marrero Sánchez, Lidunka Valdés Alonso, Aurélie Sausy, Judith M. Hübschen. Low prevalence of hepatitis delta infection in Cuban HBsAg carriers: Prospect for eliminationFrontiers in Medicine 2023; 9 doi: 10.3389/fmed.2022.1069372